Dermapharm Holding Balance Sheet Health
Financial Health criteria checks 3/6
Dermapharm Holding has a total shareholder equity of €545.0M and total debt of €1.1B, which brings its debt-to-equity ratio to 194.9%. Its total assets and total liabilities are €2.2B and €1.6B respectively. Dermapharm Holding's EBIT is €193.2M making its interest coverage ratio 3.7. It has cash and short-term investments of €159.5M.
Key information
194.9%
Debt to equity ratio
€1.06b
Debt
| Interest coverage ratio | 3.7x |
| Cash | €159.54m |
| Equity | €545.05m |
| Total liabilities | €1.62b |
| Total assets | €2.16b |
Recent financial health updates
These 4 Measures Indicate That Dermapharm Holding (ETR:DMP) Is Using Debt Extensively
Apr 29
Dermapharm Holding (ETR:DMP) Seems To Use Debt Quite Sensibly
Dec 15Dermapharm Holding (ETR:DMP) Has A Pretty Healthy Balance Sheet
Aug 28Dermapharm Holding (ETR:DMP) Has A Pretty Healthy Balance Sheet
May 29We Think Dermapharm Holding (ETR:DMP) Can Stay On Top Of Its Debt
Feb 22Is Dermapharm Holding (ETR:DMP) A Risky Investment?
Nov 17Recent updates
These 4 Measures Indicate That Dermapharm Holding (ETR:DMP) Is Using Debt Extensively
Apr 29Dermapharm Holding SE's (ETR:DMP) Price In Tune With Earnings
Feb 07Dermapharm Holding (ETR:DMP) Seems To Use Debt Quite Sensibly
Dec 15An Intrinsic Calculation For Dermapharm Holding SE (ETR:DMP) Suggests It's 24% Undervalued
Nov 17Dermapharm Holding (ETR:DMP) Has A Pretty Healthy Balance Sheet
Aug 28Dermapharm Holding SE's (ETR:DMP) Intrinsic Value Is Potentially 76% Above Its Share Price
Aug 01Dermapharm Holding (ETR:DMP) Has A Pretty Healthy Balance Sheet
May 29Is Dermapharm Holding SE (ETR:DMP) Trading At A 44% Discount?
May 03Dermapharm Holding's (ETR:DMP) Soft Earnings Are Actually Better Than They Appear
Apr 04We Think Dermapharm Holding (ETR:DMP) Can Stay On Top Of Its Debt
Feb 22Is Dermapharm Holding (ETR:DMP) A Risky Investment?
Nov 17Is Dermapharm Holding (ETR:DMP) A Risky Investment?
Aug 16Is Dermapharm Holding (ETR:DMP) A Risky Investment?
May 18Is Dermapharm Holding (ETR:DMP) Using Too Much Debt?
Feb 17These 4 Measures Indicate That Dermapharm Holding (ETR:DMP) Is Using Debt Reasonably Well
Nov 19Does Dermapharm Holding (ETR:DMP) Have A Healthy Balance Sheet?
Aug 21Is Dermapharm Holding SE (ETR:DMP) Trading At A 28% Discount?
Jul 31Is Dermapharm Holding SE (ETR:DMP) The Right Choice For A Smart Dividend Investor?
May 03Calculating The Intrinsic Value Of Dermapharm Holding SE (ETR:DMP)
Apr 16Here's Why Dermapharm Holding (ETR:DMP) Can Manage Its Debt Responsibly
Mar 25Did You Miss Dermapharm Holding's (ETR:DMP) Impressive 110% Share Price Gain?
Mar 07Is Dermapharm Holding SE's (ETR:DMP) 27% ROE Better Than Average?
Feb 15Something To Consider Before Buying Dermapharm Holding SE (ETR:DMP) For The 1.4% Dividend
Jan 29Does Dermapharm Holding (ETR:DMP) Have A Healthy Balance Sheet?
Dec 24
The Dermapharm Holding (ETR:DMP) Share Price Has Gained 45% And Shareholders Are Hoping For More
Dec 07Dermapharm Holding SE Just Missed Earnings - But Analysts Have Updated Their Models
Nov 18Financial Position Analysis
Short Term Liabilities: DMP's short term assets (€630.5M) exceed its short term liabilities (€394.5M).
Long Term Liabilities: DMP's short term assets (€630.5M) do not cover its long term liabilities (€1.2B).
Debt to Equity History and Analysis
Debt Level: DMP's net debt to equity ratio (165.6%) is considered high.
Reducing Debt: DMP's debt to equity ratio has increased from 118.7% to 194.9% over the past 5 years.
Debt Coverage: DMP's debt is well covered by operating cash flow (20.7%).
Interest Coverage: DMP's interest payments on its debt are well covered by EBIT (3.7x coverage).